BioLineRx's BL-8040 Receives Orphan Drug Designation for Treatment of AML

News   Sep 10, 2013

 
BioLineRx's BL-8040 Receives Orphan Drug Designation for Treatment of AML
 
 
FURTHER INFORMATION
 
 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE